WallStreetZenWallStreetZen

NYSEMKT: MTNB
Matinas Biopharma Holdings Inc Stock Ownership - Who owns Matinas Biopharma Holdings?

Insider buying vs selling

Have Matinas Biopharma Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MTNB insiders and whales buy or sell their stock.

MTNB Shareholders

What type of owners hold Matinas Biopharma Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc4.28%9,317,838$1.77MInstitution
Adam K. Stern4.09%8,899,382$1.69MInsider
Herbert J. Conrad3.96%8,604,510$1.63MInsider
Sargent Investment Group LLC1.76%3,818,000$725.42kInstitution
Roelof Rongen1.63%3,539,416$672.49kInsider
Blackrock Inc1.15%2,501,011$475.19kInstitution
Jennifer Lorenzo0.96%2,086,576$396.45kInsider
Raphael J. Mannino0.88%1,919,715$364.75kInsider
Abdel A. Fawzy0.79%1,720,186$326.84kInsider
Arkadios Wealth Advisors0.75%1,624,000$308.56kInstitution

1 of 3

MTNB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MTNB11.76%13.73%
OCUP1.23%98.77%Net BuyingNet Buying
XLO37.10%62.90%Net BuyingNet Buying
SABS40.51%59.49%Net Buying
APLM9.89%0.00%

Matinas Biopharma Holdings Stock Ownership FAQ

Who owns Matinas Biopharma Holdings?

Matinas Biopharma Holdings (NYSEMKT: MTNB) is owned by 11.76% institutional shareholders, 13.73% Matinas Biopharma Holdings insiders, and 74.51% retail investors. Adam K. Stern is the largest individual Matinas Biopharma Holdings shareholder, owning 8.90M shares representing 4.09% of the company. Adam K. Stern's Matinas Biopharma Holdings shares are currently valued at $1.67M.

If you're new to stock investing, here's how to buy Matinas Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.